ArticleCureus2025
Vitamin B12 Deficiency in Patients With Diabetic Peripheral Neuropathy: A Hospital-Based Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bridging gaps in diabetic neuropathy care: A Delphi-based regional consensus from the Gulf Cooperation Council.Journal of diabetes investigation · 2026Review
- Prevalence of Vitamin B12 Deficiency Among Patients With Type 2 Diabetes Mellitus on Long-Term Metformin Therapy.Cureus · 2026Article
- Correlation between vitamin B12 levels and peripheral neuropathy in diabetic patients.Bioinformation · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Diabetic peripheral neuropathy (DPN) is a serious but potentially preventable complication of diabetes mellitus, particularly in individuals with vitamin B12 deficiency. Despite clinical guidelines, routine B12 screening remains inconsistent, and hospital-based data on deficiency patterns in DPN populations are scarce. This study evaluated the frequency and determinants of B12 deficiency among patients with DPN at a tertiary care center in Pakistan. Materials and methods We conducted a hospital-based cross-sectional study on 139 patients (ages 30-60 years old) with type 2 diabetes and confirmed DPN (Michigan Neuropathy Screening Instrument score ≥4) at Lady Reading Hospital, Peshawar (August 2022-March 2025). Patients taking prior B12 supplementation or with malabsorption disorders were excluded. We measured the serum B12 levels, defining the deficiency as less than 149 ng/L. We used a multivariable logistic regression model to identify the predictors of B12 deficiency, adjusting for age, gender, and diabetes duration. Results Vitamin B12 deficiency was prevalent in 48.2% (67/139) of participants. Moreover, it was significantly higher in older patients (54.7% in the 46-60 age group vs. 13.6% in the 30-45 age group, p < 0.001) and those with longer durations of diabetes (72.8% with >5 years vs. 13.8% with 1-5 years, p < 0.001). There was no statistically significant difference among genders (50.5% males vs. 42.9% females, p = 0.38). Analysis showed that being over 45 years old and having diabetes for more than 5 years are strong factors that predict vitamin B12 deficiency. Conclusions This study demonstrates a high burden of vitamin B12 deficiency among patients with DPN, which is strongly associated with age and duration of diabetes. Implementation of routine B12 screening protocols for patients with DPN, particularly those of old age or with prolonged duration of diabetes, may help prevent neurological deterioration in this vulnerable population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.